bromodeoxyuridine has been researched along with annonacin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, HL; Chen, HW; Kao, YH; Lin, KH; Su, JH; Wu, YC; Yeh, YT; Yuan, SS | 1 |
1 other study(ies) available for bromodeoxyuridine and annonacin
Article | Year |
---|---|
Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase-3-related pathway.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Blotting, Western; Bromodeoxyuridine; Carcinoma, Transitional Cell; Caspase 3; Caspase Inhibitors; Caspases; Cell Survival; Flow Cytometry; Fluorescent Antibody Technique; Furans; G1 Phase; Humans; Lactones; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2003 |